The use of real-time patient-reported outcomes and quality-of-life data in oncology clinical practice

Michele Y. Halyard

Research output: Contribution to journalReview article

14 Scopus citations


The collection of patient-reported outcome (PRO) data such as quality of life (QoL) has provided important information in clinical trials. Increasingly, researchers are evaluating the use of this type of data in the clinical setting. The benefits of PRO/QoL data collection, methods for collecting data and the use of the data by clinicians are increasingly being studied. This article will address the issues and benefits of QoL and other PRO data collection within oncology clinical practice.

Original languageEnglish (US)
Pages (from-to)561-570
Number of pages10
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Issue number5
StatePublished - Oct 1 2011



  • data collection
  • oncology
  • patient-reported outcomes
  • quality of life
  • symptom assessment

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Cite this